Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the development of life-threatening COVID-19 are believed to disproportionately affect …

The emergence of SARS-CoV-2 in 2019 has caused a major health and economic crisis
around the globe. Gaining knowledge about its attributes and interactions with human host …

With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 post …

Background The presence of co-morbidities, including underlying respiratory problems, has
been identified as a risk factor for severe COVID-19 disease. Information on the clinical …

Viral infections are known to lead to serious respiratory complications in cystic fibrosis (CF)
patients. Hypothesizing that CF patients were a population at high risk for severe respiratory …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
people with cystic fibrosis (pwCF) can lead to severe outcomes. Methods In this …

Comprehensive clinical pictures, comorbid conditions, and long-term complications of
COVID-19 are still unknown. Recently, using a multi-omics-based strategy, we predicted …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that
leads to an acute respiratory tract infection, and for the first couple of years of the pandemic …

Introduction: The COVID-19 pandemic has challenged health care across the world, not just
by the severity of the disease and the high mortality rate but also by the consequences on …

Background Little is known about the impact of COVID‐19 and the United Kingdom's (UK)
national shielding advice on people with cystic fibrosis (CF) and their families. This study …